Literature DB >> 10436048

Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells.

G E Aranda-Abreu1, L Behar, S Chung, H Furneaux, I Ginzburg.   

Abstract

The embryonic lethal abnormal vision (ELAV)-like proteins are mRNA-binding proteins that regulate mRNA stability. The neuronal members of this family are required for neuronal differentiation. We identified the binding region of purified HuD protein to a target neuronal mRNA encoding for the tau microtubule-associated protein and demonstrated an in vivo interaction between the ELAV-like protein and its target tau mRNA. We show that treatment of neuronal cells with antisense oligodeoxynucleotides directed against HuD blocks the induction of neurite outgrowth and decreases the levels of tau mRNAs, indicating that the ELAV-like proteins are required for neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436048      PMCID: PMC6782881     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  66 in total

1.  HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.

Authors:  A Szabo; J Dalmau; G Manley; M Rosenfeld; E Wong; J Henson; J B Posner; H M Furneaux
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.

Authors:  X C Fan; J A Steitz
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

3.  RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein.

Authors:  S S Peng; C Y Chen; N Xu; A B Shyu
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

4.  Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes.

Authors:  R G Jain; L G Andrews; K M McGowan; P H Pekala; J D Keene
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 5.  Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression.

Authors:  D Antic; J D Keene
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

6.  The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs.

Authors:  S Robinow; A R Campos; K M Yao; K White
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

7.  Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1.

Authors:  F B Gao; C C Carson; T Levine; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Characterization and spatial distribution of the ELAV protein during Drosophila melanogaster development.

Authors:  S Robinow; K White
Journal:  J Neurobiol       Date:  1991-07

9.  Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor.

Authors:  P H King; T D Levine; R T Fremeau; J D Keene
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

10.  Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus.

Authors:  D Antic; J D Keene
Journal:  J Cell Sci       Date:  1998-01       Impact factor: 5.285

View more
  48 in total

1.  Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays.

Authors:  S A Tenenbaum; C C Carson; P J Lager; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.

Authors:  W Wang; M C Caldwell; S Lin; H Furneaux; M Gorospe
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

Review 3.  Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome.

Authors:  J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 4.  Candidate RNA-binding proteins regulating extrasomatic mRNA targeting and translation in mammalian neurons.

Authors:  Stefan Kindler; Michaela Monshausen
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

5.  Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal.

Authors:  S Aronov; G Aranda; L Behar; I Ginzburg
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

6.  Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins.

Authors:  A Quattrone; A Pascale; X Nogues; W Zhao; P Gusev; A Pacini; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells.

Authors:  C D Mobarak; K D Anderson; M Morin; A Beckel-Mitchener; S L Rogers; H Furneaux; P King; N I Perrone-Bizzozero
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

8.  Complex formation of the neuron-specific ELAV-like Hu RNA-binding proteins.

Authors:  Katsumi Kasashima; Eiji Sakashita; Kuniaki Saito; Hiroshi Sakamoto
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

Review 9.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

10.  Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory.

Authors:  Alessia Pascale; Pavel A Gusev; Marialaura Amadio; Tania Dottorini; Stefano Govoni; Daniel L Alkon; Alessandro Quattrone
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.